naltrexone and Suicidal Ideation

naltrexone has been researched along with Suicidal Ideation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bentzley, BS; Blasey, C; Hawkins, J; Heifets, BD; Lyons, DM; Schatzberg, AF; Sudheimer, KD; Williams, NR1
GarcĂ­a, MC1
Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J1

Reviews

1 review(s) available for naltrexone and Suicidal Ideation

ArticleYear
[Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior].
    Vertex (Buenos Aires, Argentina), 2020, Volume: XXX, Issue:148

    Topics: Borderline Personality Disorder; Buprenorphine; Dissociative Disorders; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Observational Studies as Topic; Self Mutilation; Suicidal Ideation

2020

Other Studies

3 other study(ies) available for naltrexone and Suicidal Ideation

ArticleYear
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
    Molecular psychiatry, 2019, Volume: 24, Issue:12

    Topics: Adult; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Receptors, Opioid; Suicidal Ideation; Suicide; Treatment Outcome

2019
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.
    The American journal of psychiatry, 2018, 10-01, Volume: 175, Issue:10

    Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult

2018
New obesity pill: new hopes, old fears.
    Lancet (London, England), 2010, Dec-18, Volume: 376, Issue:9758

    Topics: Anti-Obesity Agents; Antidepressive Agents, Second-Generation; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Approval; Drug Combinations; Exercise; Feeding Behavior; Humans; Life Style; Naltrexone; Narcotic Antagonists; Obesity; Seizures; Suicidal Ideation; United States; United States Food and Drug Administration

2010